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ABSTRACT 
 
Background: Many people with seizure disorder experience reproductive endocrine dysfunction 
(RED). The extent to which RED is due to intrinsic aspects of seizure disorder, and/or therapies 
used to manage epilepsy, is not well understood.  Many anti-epileptic drugs (AEDs), such as 
phenytoin or valproate, can have effects that alter endocrine status. Phenytoin is a cytochrome 
p450 enzyme-inducing drug. Valproate is a cytochrome p450 enzyme-reducing AED. Objective: 
To evaluate the effects and mechanism of some AEDs on RED in a rodent model. Hypothesis: If 
AEDs produce RED in part by altering the activities of cytochrome p450 enzymes, then AEDs 
that disrupt estrous cyclicity and/or sexual behavior will alter levels of steroids, that are products 
of p450 enzymes, in brain areas mediating such responses.   
Methods: Phenytoin (50 mg/kg, IP), valproate (165 mg/kg, IP), or placebo (40% propylene 
glycol and 10% ethanol in distilled water, IP) was administered to gonadally-intact, female 
Long-Evans rats, twice daily for four weeks. Estrous cyclicity was monitored daily. After 4 
weeks, when rats were in proestrous, they were tested for sexual receptivity. Immediately after 
completion of sex testing, brain and trunk blood were collected for later radioimmunoassay. 
Ovaries and uterus were collected and weighed as a measure of trophic effects. Results: 
Phenytoin and valproate disrupted the estrous cycle and increased aggressive behavior of rats.  
The levels of 5-pregnan-3-ol-20-one (3,5-THP) in the hippocampus and hypothalamus of 
phenytoin-treated rats were significantly lower than in controls. Levels of progesterone (P4) in 
plasma were lower among rats administered valproate compared to the controls. Conclusion:  
AEDs, such as phenytoin and valproate, disrupted estrous cylicity and sexual behavior of female 
rats, and reduced levels of hypothalamic, hippocampal, and circulating progestogens, which are 
products of p450 enzymes. 
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INTRODUCTION 
Epilepsy is a serious neurological disorder affecting over 3 million Americans and over 
50 million people worldwide (McHugh and Delanty, 2008). Those who suffer from epilepsy 
outnumber those suffering from multiple sclerosis, cerebral palsy, muscular dystrophy and 
Parkinson's disease combined (Meachem, 2009). Furthermore, approximately 200,000 new cases 
of epilepsy are diagnosed each year, 70% of which appear to be asymptomatic. Epilepsy affects 
every age group, from infants to the elderly, and can develop at any stage in life. However, in 
most cases it begins in childhood, at the onset of puberty.  On average, a person with epilepsy 
faces a mortality rate that is 2-3 times greater than that of an unaffected person; (Nouri, 2006).  
The risk of sudden death among epileptics is 24 times greater than that of the general population 
(Meachem, 2009). In summary, epilepsy is a pressing problem worldwide.  
Epilepsy is associated with Reproductive Endocrine Dysfunction, or RED, in both men 
and women. Women with epilepsy face a host of challenges, including disruption in reproductive 
health. Compared to the general population, women with epilepsy have substantially higher 
chances of developing syndromes associated with infertility, such as polycystic ovary syndrome, 
hypothalamic amenorrhea, or functional hyperprolactinemia (Bauer and Cooper-Mahkorn, 
2008). In a large clinical center 50% of women with epilepsy were found to have menstrual 
abnormalities, 20% amenorrheic and 30%  anovulatory (Engel et al, 2007). Epidemiological 
studies have shown that 10%-25% of women with epilepsy suffer from Polycystic Ovary 
Syndrome (PCOS) compared with 4-6% of women in the general population (Bauer et al, 2002). 
A study conducted in the Greater London area showed that women with epilepsy had a 
significantly reduced birth rate in comparison with women of the general population (Wallace et 
al, 1998). In addition, studies on sexual function in women with epilepsy reported variable 
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frequencies of sexual dysfunction: 14% in Egypt, 29% in Scandinavia, 36-50% in the United 
States (Morrell, 1998).  This demonstrates that RED is a common problem among women with 
epilepsy.  
It is well established that steroid hormones have great influence on reproductive 
endocrine function. The central nervous system (CNS) acts both as a target and source of sex 
steroids and of their metabolites. Neuroactive steroids are steroid hormones that produce 
functional effects through actions in the CNS. They mediate many diverse neuroendocrine 
functions (Baulieu, 1997). Among those functions are the release of GnRH, LH, and FSH which 
are important in ovulation and regulation of the duration of menstrual cycles. Neuroactive 
steroids also influence female sexual behavior (Frye et al, 2006).  An important steroid hormone 
which influences female sexual behavior is Progesterone (P4), which like all other steroid 
hormones, is derived from cholesterol. Cholesterol must first be converted to pregenolone, which 
when catalyzed by cytochrome P450 forms progesterone. P4 is the precursor of the mineral 
corticoid aldosterone which is then reduced to form the many important byproducts such as 
testosterone, estradiol, and the metabolite of P4, 5 alpha-pregnane-3,20-dione (5-DHP), which is 
further  broken down into 5-pregnan-3-ol-20-one (3,5-THP) (Frye and Paris, 2008). To 
gain insights into the nature of the effects of steroid hormones on reproductive endocrine 
function and sexual behavior, a rat model is used in this study. 
In rodent models, sexual activity is dependent on a modulator of lordosis (the 
stereotypical posture that female rodents exhibit in response to male-typical stimuli), and the 
control of behavioral processes such as aggression and anxiety (Frye and Rhodes, 2008).  3,5-
THP, a metabolite of P4, has been shown to mediate such behaviors. Rats have elevated 3,5-
THP in behavioral estrus, a period during which they are most receptive to mating and 
demonstrate more exploration, anti-anxiety, and pro-social behaviors than rats in diestrous, a 
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period in which they are least receptive to mating (Frye, Paris, and Rhodes 2008). Elevated 
3,5-THP levels, independent of P4,  also increase hopping and darting behavior (proceptivity) 
that female rats make toward male rats to achieve sexual contacts. Overall, the metabolism and 
presence of 3,5-THP is a critical factor in the success of modulating rodent mating. 
3,5-THP has multiple targets in the brain to modulate its effects on sexual behavior. In 
the ventral tegmental area (VTA) of the midbrain, 3,5-THP works to control the 
consummatory aspects of sexual behavior; this includes stimulating and controlling lordosis. 
Decreased 3,5-THP concentrations in the midbrain region significantly decrease lordosis 
responses (Frye et al., 2008). The 3,5-THP concentrations at GABAergic substrates in the 
hippocampus and hypothalamus work to mediate motivational and anxiety aspects of sexual 
behavior. When there are increased levels of 3,5-THP in the hippocampus, female rats 
demonstrate less species-typical anxiety-like behavior and conspecific-avoidance, spending more 
time in affiliation with their mates (Frye and Rhodes, 2008). Thus, the role of 3,5-THP in the 
different parts of the rodent’s brain dramatically affect mating behavior. 
 Anti epileptic drugs (AEDs) have the potential to affect brain function and, more 
specifically, the production and metabolism of steroid hormones, like 3,5-THP, which affect 
sexual behavior. Studies done on women taking AEDs show that the occurrence of RED is 
significantly higher in those that take cytochrome p450 enzyme-inducing AEDs, such as 
phenytoin, than those that do not (Sheth and Montouris, 2008). AEDs which induce cytochrome 
p450 increase the metabolism of gonadal and adrenal steroid hormones which induce the 
synthesis of sex hormone-binding globulin. As the potential for protein binding ability increases, 
the biologically active fraction of hormone levels in circulation decreases. This reduction in sex 
steroid hormones is commonly associated with sexual dysfunction (Morrell, 2005). Prior studies 
have demonstrated that serum concentrations of estrogens and androgens are indeed reduced in 
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women with epilepsy receiving enzyme inducing AEDs (Morrell, 2005). This, in turn, is 
associated with reproductive endocrine dysfunction such as polycystic ovaries and 
hypogonadotropic hypogonadism (Macphee et. al., 1998; Stoffel-Wagner et. al., 1998). Similar 
to cytochrome p450 enzyme inducing AEDs, cytochrome p450 enzyme-reducing AEDs, such as 
valproate, have marked effects on steroid hormone levels. Enzyme reducing AEDs are 
progesterone antagonists and they dramatically increase the presence of circulating androgens 
(Isojarivi et. al., 2004). This consequently disrupts the ratio of androgens to estradiol, causing 
reproductive problems such as polycystic ovaries (Morrell, 2003).  The critical ratio of 
androgens to estradiol is in other words the ratio between female and male sex steroid hormones. 
The most common type of RED experienced with valproate users is anovulatory cycles (Morrell, 
2004). Overall, the AEDs, phenytoin and valproate, which have been shown to alter steroid 
hormone levels in the brain, valproate reducing the amount of estradiol and progesterone in 
circulation and phenytoin reducing the metabolically active levels of steroid hormones, can cause 
many undesirable and serious side effects.  
Studies such as this one are critical in understanding and evaluating the effects and 
mechanism of some AEDs on RED. It is difficult, however, to determine whether RED is a 
direct result of epilepsy or the AED treatment used to combat the disorder. The rat model is 
helpful in isolating the effects of the AEDs on steroid hormone functions as rats are epilepsy 
free. Subjecting human beings to similar epilepsy experimentation presents ethical dilemmas as 
it is simply not feasible to withhold treatment from a control group due to the devastating 
consequences of epileptic seizures which may include brain damage or death. The data suggests 
phenytoin, a cytochrome p450 enzyme inducing drug, and valproate, a cytochrome p450 enzyme 
reducing drug, could have marked effects on steroid hormone levels. To determine if this is the 
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case, we correlated steroid levels in the brain areas controlling estrous cyclicity and sexual 
behavior in rats treated with AEDs that potentially produce RED in humans. 
MATERIALS & METHODS  
 These methods were pre-approved by the Institutional Animal Care and Use Committee 
at The University at Albany-SUNY. 
Subjects 
Female, intact rats (N=38) were approximately 50 days old and were acquired from our 
breeding colony at The University at Albany-SUNY. Rats were housed in polycarbonate cages (3-
4 rats per cage), in a temperature- (21 ± 1 C) and humidity- (50 ± 5 %) controlled room in our 
Laboratory Animal Care Facility. Rats were maintained on a reversed 12 hr light-dark cycle (lights 
off at 0800 h) and had ad libitum access to food and water throughout the study. 
Determination of Estrous Cycle Phase 
 Vaginal epithelium was obtained between 0800-0900 h via lavage and examined 
microscopically daily to determine the day of the estrous cycle. Cycle phase was determined per 
previous methods (Frye, 2001; Marcondes et al., 2002). Briefly, the proestrous phase, the time 
when endogenous estrogens and progestogens peak, was characterized by the presence of many 
nucleated epithelial cells. The estrous phase, when estrogens are low and progestogens are 
declining was distinguished by cornification of the vaginal epithelium. Cornification is the 
stratification of epidermal tissues and the process of forming an epidermal barrier on the cells 
coupled with the production of keratin (Lippens, 2005). It is characterized by cells with very 
rugged edges and the loss of nuclei and organelles. The diestrous phase, when estrogens and 
progestogens are at nadir, was characterized by the lack of epithelial cells and the presence of 
leukocytic cells. Rats were cycled through two estrous cycles (demonstrating proestrous once 
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every 4-5 days) prior to manipulation in order to verify typical estrous cyclicity. Only rats that 
demonstrated 4-5 day cycles before manipulation were utilized in the study.  
 
Preparation of AED Regimen 
 AEDs were purchased from Sigma-Aldrich (St. Louis, MO). Phenytoin was dissolved 
in a propylene glycol vehicle (40% propylene glycol and 10% ethanol in distilled water) and 
valproate was dissolved in 0.9% sodium chloride.  
Procedure 
   Rats were randomly assigned to receive twice daily, intraperitoneal (IP) injections of 
phenytoin (50 mg/kg, IP), valproate (165 mg/kg, IP), or a commensurate volume of vehicle (40% 
propylene glycol and 10% ethanol in distilled water, IP) at 11:00 h and 15:00 h for at least 28 
days. During this time, vaginal cytology was recorded daily. After 28 days of treatment, rats 
were tested in the mating paradigm described below at their next sexually-receptive (proestrous) 
phase of their estrous cycle. The rats continued to receive AED treatment until sex-testing. 
Because of the need to test rats when sexually-receptive, there were differences in the length of 
treatment among some rats (the treatment range was 28-33 days) but these differences did not 
account for a significant amount of variance on any measure of parameter. Immediately 
following completion of sex-testing; brain, ovaries, uterus, and serum were collected and wet 
weights were documented. All tissues were stored at -80 ºC until the radioimmunoassay was 
performed. 
Sex Testing 
Sex testing was conducted in a chamber 37.5 x 75 x 30 cm as previously reported (Hardy 
& DeBold, 1972; Frye et al. 2000). Sexually-vigorous male studs were briefly paired with 
sexually-receptive stimulus females in order to ensure immediate mounting. Each experimental 
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female rat was placed in the chamber with a stimulated male and observed until either ten mounts 
were achieved, until male ejaculation, or for ten minutes if neither ten mounts nor ejaculation were 
achieved. Behavior was observed by two investigators, and mean scores were utilized in all 
behavioral analyses. The frequency and intensity of lordosis (quantified by rating of dorsiflexion 
on a scale of 0–3) in response to male mounting was recorded (Hardy & DeBold, 1972). In 
addition, the frequency of proceptive (hopping, darting, ear-wiggling) and aggressive 
(vocalizations, defensive posture) behaviors were recorded as described (Frye et al 2001). 
Tissue Preparation 
 Brains were kept on ice and the midbrain, hippocampus, hypothalamus, and cortex 
were removed, and the remaining tissue without the cerebellum was used as a control (“inter-
brain”) (Frye and Rhodes, 2006ab). Following the extractions of the separate brain regions, 
steroids were extracted from brain tissue as described below.  
Radioimmunoassay for Steroid Hormones 
P4, 5 alpha-pregnane-3,20-dione (5-DHP), 3,5-THP, and Androstane-3a-Diol-G (3-diol) 
concentrations were measured using the previously reported methods described below (Choi and 
Dallman, 1999; Frye and Bayon, 1999; Frye et al., 1996). Following tissue collection, some 
brains were frozen on dry ice, blood was centrifuged, the serum saved, and tissues were stored at 
-80 oC for later analysis.  
Radioactive Probes  
 The radioactive probes used for the assays were as follows: [3H] P4 (catalog number 
NET-208) with a specific activity of 47.5 Ci/mmol; [3H]3,5-THP (catalog number NET-1047) 
with a specific activity of 65.0 Ci/mmol; 5-DHP catalog number (NET-1047) with a specific 
activity of 65.0 Ci/mmol, 3-diol (catalog number NET-806) with a specific activity of 41.00 
Ci/mmol were purchased from Perkin Elmer (Boston, MA). 
Antiepileptic drugs and reproductive function 9 
Extraction of Steroids from Serum  
 P4, 5-DHP, 3,5-THP, and 3-diol were extracted from serum with ether following 
incubation with water and 800 cpm of 3H steroid (Frye and Bayon, 1999). Test tubes containing 
steroid and ether were evaporated to dryness in a speed vacuum. Dried down samples were 
reconstituted with pH 7.2 phosphate assay buffer to the original serum volume.  
Extraction of Steroids from Brain Tissues  
 P4, 5-DHP, 3,5-THP, and 3-diol were extracted from brain tissues following 
homogenization with a glass/glass homogenizer in 50% methanol, 1% acetic acid.  Tissues were 
centrifuged at 3,000 x g and the supernatant was chromatographed on Sepak-cartridges. Steroids 
were washed with 50 % methanol then eluted with 100% methanol. Solvents were removed 
using a speed vacuum. The samples were reconstituted in 500 l of assay buffer.  
Antibodies  
 The P4 antibody (P#337 from Dr. G.D. Niswender, Colorado State University) was 
diluted 1:30,000 and typically binds between 30% and 50% of [3H]P4. The 5-DHP (X-947) and 
3,5-THP antibodies (#921412-5, purchased from Dr. Robert Purdy, Veterans Medical Affairs, 
La Jolla, CA) was diluted 1:5000 and binds between 40-60% of [3H]3,5-THP. The 3-diol 
antibody (X-144; Dr. P.N. Rao, Southwest Foundation for Biomedical Research, San Antonio, 
TX) was diluted 1:20,000 and binds approximately 96% of [3H]3-diol . 
Set-up and Incubation of Radioimmunoassays  
The range of the standard curves were 0-8000 pg for P4, 5-DHP, and 3,5-THP, and 0-
2000 pg for 3-diol. Standards were added to assay buffer followed by addition of the diluted 
antibody and [3H] steroid. Total assay volumes were 800 l for P4, 900l for 3-diol, 950 l for 
5-DHP, and 1250 l for 3,5-THP. All assays were incubated overnight at 4oC. 
Termination of Binding  
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Extraction of the free steroids was accomplished by the rapid addition of dextran-coated 
charcoal. Following incubation with charcoal, samples were centrifuged at 3000 x g and the 
supernatant was pipetted into a glass scintillation vial with 5 ml scintillation cocktail. Sample tube 
concentrations were calculated using the logit-log method of Rodbard and Hutt (1974), 
interpolation of the standards, and correction for recovery with Assay Zap. The logit-log method 
is an empirical technique to convert the sigmoid calibration curve into a reasonably straight line, 
so that a straight line approximation is acceptable. The inter- and intra-assay reliability co-
efficients were: for P4, 0.11 and 0.04, for 5-DHP, 0.11 and 0.04, for 3,5-THP 0.09 and 0.04, 
and for 3-diol 0.09 and 0.04.  
Statistical analyses 
The significance of differences in estrous cyclicity were determined via chi-square 
analysis. Main effects on tissue weights, neuroendocrine, and behavioral measures were evaluated 
by separate one-way analyses of variance (ANOVAs) with the AED treatment condition (vehicle, 
phenytoin, valproate) as the independent variable. Differences between groups were determined 
via Fisher’s protected least significant differences (PLSD) post-hoc tests. The alpha level for 
statistical significance was p less than 0.05.  Trends were reported when p was less than 0.10. 
RESULTS 
Estrous Cyclicity and Uterine/Ovarian Weight  
AED treatment significantly altered estrous cyclicity among female rats [χ2(2, N = 38) = 
5.67, p < 0.05]. Over the 4 week study, an average of 8 ± 2 cycles was observed. Of the thirteen 
females administered phenytoin, and the thirteen females administered valproate, only two from 
each group demonstrated a normal 4-5 day cycle following treatment. Of the twelve female 
controls administered vehicle, nine demonstrated normal 4-5 day cycles (Figure 1). Compared to 
75 % of vehicle rats which cycled properly, only 15% of phenytoin (p<.05) and  15% valproate 
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rats (p<.05) cycled properly (Figure 1). Neither uterine nor ovarian weight was significantly 
affected by phenytoin or valproate treatment compared to the control.  
 
Neuroendocrine Endpoints 
AED treatment significantly altered CNS steroid concentrations in some regions but not 
in others. First we look at areas related to the control of sexual behaviors: the hippocampus, 
midbrain, and hypothalamus. In the hippocampus, 3,5-THP levels were significantly lower in 
phenytoin-administered rats in comparison to valproate and/or vehicle groups (p<.05; Figure 2 
and Table 2). Phenytoin rats also exhibited a trend of increased levels of P4 in the hippocampus 
compared to the vehicle group (p<.10; Table 2). There were no other differences in steroid 
hormone levels of 5-DHP or 3-diol in the hippocampus.  
In,the hypothalamus, phenytoin rats exhibited a trend of lower 3,5-THP levels (p<.10; 
Table 2) compared to the vehicle group.  There were no other differences in steroid hormone 
levels of P4, 5-DHP, and 3-diol in the hypothalamus.  There was also, no differences of 
steroid hormone levels found in the Midbrain.  Overall, in areas controlling sexual behavior there 
was only altered steroid hormone differences in the hippocampus and hypothalamus, but not the 
midbrain. 
As a control measure, there was no difference between the phenytoin group and the 
vehicle group in concentrations of P4, 5-DHP, 3,5-THP and 3-diol in the cortex, and 
interbrain regions (Table 2). Phenytoin rats also exhibited no differences among serum 
concentration as compared to the Vehicle group (Table 2). Although differences in steroid 
hormone levels for phenytoin rats were observed in the hippocampus and hypothalamus, there 
was no difference compared to the vehicle group in the midbrain, cortex, and serum. 
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Valproate rats showed a significant decrease in serum P4 and a significant increase in 
serum 5-DHP concentrations (p<.05; Table 2). The valproate group exhibited no difference in 
comparison to the vehicle group in concentrations of P4, 5-DHP, and 3,5-THP and 3-diol 
in all 5 brain regions. Overall, valproate had no effect on steroid hormone levels in the brain, but 
significantly altered their concentration in the blood (Table 2). 
Behavioral Endpoints 
Phenytoin rats exhibited a significantly higher aggression quotient (aq) and lower 
proceptivity quotient (pq) than the vehicle rats (p<.05) (Figure 3). However, phenytoin rats 
showed no main effect for lordosis quotient (lq), lordosis rating (lr), mount latency or total sex 
duration (Table 1).  
Valproate rats showed a tendency to be more aggressive and less proceptive during sex 
testing (Figure 3). Although valproate rats exhibited higher aggression and were less proceptive 
during sex testing, there was no main effect for lq, lr, mount latency or total sex duration (Table 
1).  
DISCUSSION 
Our hypothesis which stated that the anti-epileptic drug phenytoin would produce 
reproductive endocrine dysfunction among female rats was supported. Eleven out of the thirteen 
rats injected with phenytoin exhibited abnormal cycling compared to only three out of the eleven 
rats in the control group that showed abnormal cycling. In addition, the study showed a 
significant increase in aggression and a tendency to exhibit decreased proceptivity during 
standard sex testing in rats treated with phenytoin. The control group of rats, treated with vehicle, 
exhibited no increased aggression or decreased proceptivity or abnormal cycling in our study. 
Increased aggression, and decreased proceptivity are indications of reproductive endocrine 
dysfunction (Morrell, 2003). 
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Our hypothesis further stated that the anti-epileptic drug phenytoin would produce 
reproductive endocrine dysfunction among female rats through its effects on progesterone and its 
5-reduced metabolites. Evaluation of hormone dynamics in the brain for the phenytoin rats 
showed significantly lowered 3,5-THP levels in the hippocampus and hypothalamus. The 
significant decrease in the 3,5-THP levels in the hippocampus correlates strongly to the 
marked increase in aggressive and anti social behavior of female rats during mating. This data 
correlated with our predictions and further supported our hypothesis.  
These results are also consistent with previous studies. The data from this study 
demonstrate that AEDs phenytoin significantly disrupt estrous cyclicity which is consistent with 
the findings of Martha J. Morrell (Morell 2003; Morrell et al, 2003). To cycle properly it is 
essential to have proper amounts of free steroid hormones in circulation (Frye, 2008). Enzyme 
inducing AEDs reduce the levels of free steroid hormones in circulation due to the effect of 
globulin-binding proteins (Morrell, 2005).  
Our hypothesis which stated that the anti-epileptic drug valproate would produce 
reproductive endocrine dysfunction among female rats was supported. Eleven out of the thirteen 
rats injected with valproate exhibited abnormal cycling compared to only three out of the eleven 
rats in the control group that showed abnormal cycling. In addition, rats treated with Valproate 
showed decreased proceptivity. The control group of rats, treated with vehicle, exhibited no 
decreased proceptivity and little abnormal cycling in our study. Abnormal cycling and decreased 
proceptivity are indications of reproductive endocrine dysfunction (Morrell, 2005).  
The data from this study demonstrate that the AED valproate significantly disrupts 
estrous cyclicity which is consistent with previous studies such as the findings of Martha J. 
Morrell (Morell 2003; Morrell et al, 2003). To cycle properly it is essential to have normal levels 
of both estrogen and progesterone (Morrell, 2003). We predicted that valproate would produce 
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reproductive endocrine dysfunction among female rats through its effects on progesterone and its 
5-reduced metabolites. Our study shows that valproate significantly reduced the levels of P4 in 
serum. This disruption in the P4 concentrations caused a higher gonadal and adrenal androgen to 
progesterone ratio which correlates closely with ovulatory dysfunction (Morrell and Montouris, 
2004).  This is consistent with the fact that valproate is documented to have strong effects on 
menstrual cycles.  
In addition, our study extends the current literature as it examined the dynamics of how 
AEDs produce REDs by closely monitoring the role of steroid hormones in the mid brain region, 
the hippocampus and hypothalamus in relation to normal sexual activity. The rats treated with 
phenytoin exhibited no signs of consummatory dysfunction, but showed significant motivational 
dysfunction in the form of increased aggression and antisocial behavior during mating. 
Evaluation of hormone levels in the brain for these rats showed significantly lowered 3,5-
THP levels in the hippocampus and hypothalamus, and minimal effects on 3,5-THP levels in 
the midbrain. The significant decrease in the 3,5-THP levels in the hippocampus correlates 
strongly to the marked increase in aggressive and anti social behavior of female rats during 
mating. The minimal effects on 3,5-THP levels in the midbrain correlates to the little, if any, 
effect on the lordosis ratings and quotients of the rats in the study.  
 
Future Direction 
In the future, there are plans to repeat the same study with the addition of another AED, 
lamotrogene, which is believed to have minimal, if any, effect on steroid hormones. The group 
receiving lamotrogene will serve as the negative control since this specific AED is not supposed 
to affect the hormone levels and thus should not produce the side effect of sexual dysfunction. 
Comparing the results of the rats receiving phenytoin and valproate treatment with the negative 
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control group will help us understand the effects of the treatment on sexual dysfunction in rats 
more accurately. This will show whether the sexual dysfunction experienced is primarily due to 
phenytoin and valproate’s effects on steroid hormones as opposed to other mechanisms. 
 
CONCLUSION 
Using a rat model made it possible to isolate the effects of phenytoin and valproate 
treatments on RED independent of epilepsy. The results of the study clearly show that both 
phenytoin and valproate disrupt the estrous cycle and increase reproductive endocrine 
dysfunction among female rats. In addition, this study indicates that phenytoin significantly 
decreases 3,5-THP levels in the hippocampus, while having no effect on the concentrations of 
steroid hormones in the midbrain. 
Anti-epileptic drugs have worked wonders for epileptic patients, but it is essential to re-
examine their widespread use for other disorders. AEDs are often used in treating a variety of 
health problems from bi-polar disorder to congenital heart defects to chronic pain. Gaining a 
better and a more accurate understanding of the potential side effects of AEDs will help 
physicians weigh the need for AED treatment against the side effects when considering the 
drugs. Research studies such as this one will promote such understanding and may provide 
helpful insights into the development of improved AED treatments.  
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FIGURE LEGENDS 
 
Figure 1 Differences in Cyclicity. Percent cycling was determined by dividing the number of 
proper 4-5 day estrous cycles in assigned group divided by total number of cycles observed 
 (* Denotes a significant difference p <.05), (# Denotes a p< .10) 
Figure 2 Differences in 3,5-THP, and 3-diol steroid hormone levels in the hippocampus. 
Concentrations were calculated using the logit-log method of Rodbard and Hutt (1974), 
interpolation of the standards, and correction for recovery with Assay Zap. 
(* Denotes a significant difference p <.05), (# Denotes a p< .10) 
Figure 3 Differences in Proceptivity and Aggressive behavior. Proceptivity quotient was 
determined by number of mounts with female displaying proceptive behavior divided by number 
of mounts. Aggressive quotient was determined by number of mounts followed by aggressive 
behavior divided by total amount of mounts. 
  (* Denotes a significant difference p <.05), (# Denotes a p< .10) 
Table 1: Standard Sex testing measures. Lordosis quotient was determined by number of mounts 
with female displaying lordosis divided by total amount of mounts. Lordosis rating was 
determined by the sum of the lordosis ratings divided by the total number of rats. Mount latency 
was found by time required for male to attempt the first mount. 
(* Denotes a significant difference p <.05), (# Denotes a p< .10) 
Table 2: Endocrine Data. Concentrations were calculated using the logit-log method of Rodbard 
and Hutt (1974), interpolation of the standards, and correction for recovery with Assay Zap. 
(* Denotes a significant difference p <.05), (# Denotes a p< .10) 
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Table 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Vehicle 
 
Phenytoin 
 
Valproate 
 
Lordosis quotient (%) 
 
84.2 ± 9 
 
89.3 ± 7 
 
85.8 ± 10 
 
Lordosis Rating (1-4) 
 
1.9 ± 0.2 
 
2.0 ± 0.3 
 
1.7 ±.25 
 
Sex Total Duration (s) 
 
196.3 ± 38 
 
146.2 ± 36 
 
170 ± 46 
 
Mount Latency (s) 
 
33.6 ± 15 
 
39.5 ± 10 
 
32.5 ± 10 
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Table 2 
 
  
 
Saline 
 
Phenytoin 
 
Valproate 
 
Midbrain 
 
  
 
  
 
  
 
P4 
 
5.6 ± 2.5 
 
3.5 ± .7 
 
5.2 ±  2.1 
 
5-DHP 
 
38.9 ± 1.2 
 
61.9 ± 18.7 
 
68.6 ± 19.8 
 
3,5-THP  12.7 ± 3.9 
 
13.6 ± 5.2 
 
8.0 ± 2.6 
 
3-diol  
 
7.1 ± 1.24 
 
8.1 ± 2.5 
 
6.5 ± 1.3 
 
Hypothalmus 
 
  
 
  
 
  
 
P4 
 
6.5 ± 2.0 
 
4.3 ± 1.3 
 
6.8 ± 2.2 
 
5-DHP 
 
69.1 ± 6.2 
 
51.0 ± 12.4 
 
35.5 ± 15.3 
 
3,5-THP  57.1 ± 16.7 
 
 28.0 ± 9.0 # 
 
31.7 ±  8.7 
 
3-diol  
 
16.7 ±  4.9 
 
20.9 ± 4.9 
 
20.2 ± 4.2 
 
Hippocampus 
 
  
 
  
 
  
 
P4 
 
7.4 ± 1.8 
 
15.9 ± 4.1 # 
 
11.6 ± 3 
 
5-DHP 
 
 
26.8 ± 9.5 
 
31.0 ±  7.3 
 
14.2 ± 4.4 
 
3,5-THP 19.8 ± 4.6 8.6 ± 2.3 22.1 ± 4.2 
3-diol  
 
4.2 ± 0.6 2.3 ± 0.5 3.7 ± 1.3 
Cortex 
 
  
 
  
 
  
 
P4 
 
14.9 ± 3 
 
15.6 ± 2 
 
18.4 ± 2.7 
 
5-DHP 
 
13.4 ± 3.7 
 
10.8 ± 4.1 
 
16.9 ± 4.1 
 
3,5-THP  15.6 ±  5.1 
 
15.2 ± 5.1 
 
8.9 ± 3.7 
 
3-diol  
 
4.7 ± 1.7 
 
3.1 ± .4 
 
4.6 ± 1.4 
 
InterBrain 
 
  
 
  
 
  
 
P4 
 
1.7 ± .5 
 
1.0 ± .32 
 
2.2 ± .76 
 
5-DHP 
 
39.7 ± 9.7 
 
43.1 ± 12.6 
 
28.2 ± 10.0 
 
3,5-THP  13.7 ± 4.1 
 
15.2 ± 1.5 
 
17.1 ± 5.7 
 
3-diol  
 
4.9 ± 1.1 
 
4.9 ± 1.8 
 
3.3 ± 1.0 
 
Serum 
 
  
 
  
 
  
 
P4 
 
25.0 ±  6.2 
 
19.3 ± 4.5 
 
12.4 ± 3.1 *   
 
5-DHP 
 
23.8 ± 12.4 
 
36.2 ± 9.7 
 
 
72.7 ± 14.0 * 
 
3,5-THP  54.2 ± 11.5 
 
49.6 ± 12.4 29.8 ± 10.1 # 
 
3-diol  
 
24.6 ± 4.7 
 
18.7 ± 2.4 
 
21.8 ± 2.5 
 
